Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer [Phase 2]
Phase 2 window study comparing amcenestrant (SAR439859) to letrozole in postmenopausal ER-positive, HER2-negative breast cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer [Phase 2]
Phase 2 study evaluating predictors of response to dose-dense docetaxel and epirubicin in Stage III breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: To Enhance Breast Cancer Survivorship of Asian Americans [NA]
A completed clinical trial conducted by Emory University focused on enhancing survivorship for Asian American breast cancer patients; result…
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer [Phase 3]
Phase 3 clinical trial update for a precise therapy in refractory HER2-positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038 [Phase 2]
Phase 2 trial update on a novel double-target therapy combined with chemotherapy for first-line treatment of HER2-positive breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer [Phase 2]
Phase 2 trial update of KN026 in combination with docetaxel as neoadjuvant therapy for HER2-positive breast cancer (status unknown).
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer [Phase 2]
Phase 2 trial update for KHK2375 in advanced or recurrent breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC [Phase 2]
Phase 2 clinical trial investigating molecular mechanisms of resistance and sensitivity to palbociclib re-challenge in ER-positive metastati…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a vaccine therapy in combination with trastuzumab for patients with Stage IV HER2-positive breast cancer or ova…
-
FDA approval · 2022-06-15FDA Approved: EXEMESTANE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for exemestane (Cipla USA Inc.). This action approves a supplemental change to the product's lab…
-
FDA approval · 2022-06-15FDA Approved: EXEMESTANE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
FDA approved a supplemental application for Exemestane from Breckenridge Pharmaceutical, Inc. The approval pertains to the generic product u…
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study [Phase 4]
Phase 4 clinical trial update on volatile anesthesia and perioperative outcomes in cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy [Phase 2]
Phase 2 trial update on cryoablation with tirelizumab and bevacizumab in liver-metastatic metastatic breast cancer after multiline therapy; …
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer [Phase 1, Phase 2]
Phase I-II study updating on interferon-gamma in HER2-positive breast cancer; the trial has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC [Phase 2]
Phase 2 study evaluating chidamide plus chemotherapy as neoadjuvant treatment for HR+/ HER2- breast cancer; status and results not disclosed…
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer [Phase 2]
Phase 2 clinical trial investigating stellate ganglion block for hot flashes in Hispanic women with breast cancer; status terminated with re…
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. [Phase 1, Phase 2]
Open-label Phase Ib/II trial evaluating ribociclib with trastuzumab or T-DM1 in advanced/metastatic HER2-positive breast cancer; study compl…
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for weekly Utidelone in HER2-negative inoperable locally advanced or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating palbociclib in combination with anastrozole for Stage 2-3 estrogen receptor-positive, HER2-negative breast cancer; …
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment [Phase 3]
Phase 3 trial evaluating hypofractionated irradiation at regional nodal area for breast cancer compared to standard treatment; currently rec…
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial update for ARX788 in HER2-positive metastatic breast cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) [Phase 3]
Phase 3 clinical trial protocol investigating Herceptin (trastuzumab) as adjuvant therapy with reduced chemotherapy exposure for HER2-positi…
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over. [Phase 2]
A Phase 2 trial of trastuzumab and pertuzumab with hormonal therapy or chemotherapy in women aged 60 and over with metastatic breast cancer …
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ [Phase 3]
A Phase 3 trial evaluating radiation therapy with or without optional tamoxifen for treating ductal carcinoma in situ in women has completed…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Therapeutic Dose Monitoring (TDM) of Tamoxifen [Phase 2]
Phase 2 clinical trial update on therapeutic dose monitoring of tamoxifen for breast cancer.